Journal of Intellectual Property Law & Practice Advance Access originally published online on April 18, 2008
Journal of Intellectual Property Law & Practice 2008 3(6):354-356; doi:10.1093/jiplp/jpn067
| ||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author (2008). Published by Oxford University Press. All rights reserved
Current Intelligence |
Boxing clever or rope-a-dope? The drugs repackaging rumble is going the distance
Linklaters LLP, London
Boehringer Ingelheim KG and another v Swingward Ltd: Boehringer Ingelheim KG v Dowelhurst Ltd and another: Glaxo Group Ltd v Swingward Ltd: Glaxo Group Ltd and another v Dowelhurst Ltd: Smithkline Beecham PLC and another v Dowelhurst Ltd: Eli Lilly & Co v Dowelhurst Ltd [2008] EWCA Civ 83, 21 February 2008
The Court of Appeal for England and Wales resumed, following judgment by the European Court of Justice (the ECJ) in April 2007 on questions it had referred to the ECJ, the hearing of certain appeals and cross-appeals against two High Court decisions concerning alleged trade mark infringement through co-branding or re-branding by parallel importers.
Correspondence: Email: alex.batteson{at}linklaters.com